Literature DB >> 8254001

Serologic diagnosis of tuberculosis through assays of lipoarabinomannan antigen or antibody or lysozyme level.

S C Arya.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8254001      PMCID: PMC266033          DOI: 10.1128/jcm.31.10.2836-2838.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  8 in total

1.  [The importance of BCG vaccination in Mexico].

Authors:  G Cano Pérez
Journal:  Salud Publica Mex       Date:  1975 Sep-Oct

2.  Efficacy of leprosy vaccine.

Authors:  P E Fine; P G Smith
Journal:  Nature       Date:  1992-12-03       Impact factor: 49.962

Review 3.  BCG vaccination and cancer.

Authors:  J M Grange; J L Stanford
Journal:  Tubercle       Date:  1990-03

4.  Use of serum antibody and lysozyme levels for diagnosis of leprosy and tuberculosis.

Authors:  K A Near; M J Lefford
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

5.  The serodiagnosis of tuberculosis in children: an evaluation of an ELISA test using IgG antibodies to M. tuberculosis, strain H37 RV.

Authors:  G Hussey; M Kibel; W Dempster
Journal:  Ann Trop Paediatr       Date:  1991

6.  Evaluation of lipoarabinomannan for the serological diagnosis of tuberculosis.

Authors:  E Sada; P J Brennan; T Herrera; M Torres
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

Review 7.  Postulated epidemiology of Mycobacterium ulcerans infection.

Authors:  J Hayman
Journal:  Int J Epidemiol       Date:  1991-12       Impact factor: 7.196

8.  Detection of lipoarabinomannan as a diagnostic test for tuberculosis.

Authors:  E Sada; D Aguilar; M Torres; T Herrera
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

  8 in total
  1 in total

1.  Infrequent detection of lipoarabinomannan antibodies in human immunodeficiency virus-associated mycobacterial disease. Swiss HIV Cohort Study.

Authors:  K Boggian; W Fierz; P L Vernazza
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.